The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: Current state, unmet needs and future directions

European Heart Journal

Volumn 35, Issue 23, 2014, Pages 1526-1532

  Huber, Kurt ^a   Gersh, Bernard J ^b   Goldstein, Patrick ^c   Granger, Christopher B ^d   Armstrong, Paul W ^e  

^a WILHELMINEN HOSPITAL   (Austria)

^b Mayo Clinic College of Medicine   (United States)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d DUKE UNIVERSITY   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Myocardial infarction; Organization; Primary percutaneous coronary intervention; STEMI networks; Thrombolytic therapy

Indexed keywords

HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; TICAGRELOR; FIBRINOLYTIC AGENT;

FIBRINOLYTIC THERAPY; GEOGRAPHIC DISTRIBUTION; HEART MUSCLE REPERFUSION; HUMAN; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; COMMUNITY CARE; CORONARY CARE UNIT; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; FORECASTING; HEALTH; HEALTH SERVICE; INTERNATIONAL COOPERATION; MYOCARDIAL INFARCTION; ORGANIZATION AND MANAGEMENT; PROCEDURES; PUBLIC RELATIONS; STANDARDS; TIME TO TREATMENT; TRENDS;

COMMUNITY NETWORKS; CORONARY CARE UNITS; EMERGENCY MEDICAL SERVICES; EMERGENCY TREATMENT; FIBRINOLYTIC AGENTS; FORECASTING; GLOBAL HEALTH; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNATIONAL COOPERATION; INTERPROFESSIONAL RELATIONS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME-TO-TREATMENT;

EID: 84902584155     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu125     Document Type: Review

References (67)

1. Armstrong PW, Westerhout CM, Welsh RC. Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction. Circulation 2009;119:1293-1303.
2. O'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM,Woo YJ, Zhao DX. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e78-e140.
3. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
4. Graham KJ, Strauss CE, Boland LL, Mooney MR, Harris KM, Unger BT, Tretinyak AS, Satterlee PA, Larson DM, Burke MN, Henry TD. Has the time come for a national cardiovascular emergency care system? Circulation 2012;125:2035-2044.
5. Van deWerf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-2945.
6. Kushner FG, Hand M, Smith SCJ, King SBR, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DEJ, Green LA, Hochman JS, Jacobs AKJ, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 Focused Updates:ACC/ AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/ SCAIGuidelineson Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline. Circulation 2009;120:2271-2306.
7. Welsh RC, Travers A, Huynh T, Cantor WJ. Canadian Cardiovascular Society Working Group: providing a perspective on the 2007 focused update of the American College of Cardiology and American Heart Association 2004 guidelines for the management of ST elevation myocardial infarction. Can J Cardiol 2009;25:25-32.
8. WijnsW, Kolh P, Danchin N, Di Mario C, FalkV, FolliguetT, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-2555.
9. Chew DP, Aroney CN, Aylward PE, Kelly A-M, White HD, Tdeman PA,Wadell J, Azadi L, Wilson AJ, Ruta L-AM. 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the Management of Acute Coronary Syndromes (ACS) 2006. Heart Lung Circ 2011;20: 487-502.
10. Huber K, Goldstein P, Danchin N, Fox KA, Welsh RC, Granger CB, Henry TD, Gersh B. Enhancing the efficacy of delivering reperfusion therapy: a European and North American experience with ST-segment elevation myocardial infarction networks. Am Heart J 2013;165:123-132.
11. Armstrong PW; WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006;27:1530-1538.
12. Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI(NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol 2010;55:102-110.
13. Danchin N, Coste P, Ferrières J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T; for the FAST-MI Investigators. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segmentelevation acute myocardial infarction: data from the French registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008;118:268-276.
14. Fox KA, Huber K. A European perspective on improving acute systems of care in STEMI: we know what to do, but how can we do it? Nat Clin Pract Cardiovasc Med 2008;5:708-714.
15. Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR, Lips DL, Madison JD, Menssen KM, Mooney MR, Newell MC, Pedersen WR, Poulose AK, Traverse JH, Unger BT,Wang YL, Larson DM. A regional system to provide timely access TP precutaneous coronary intervention for ST-elevation myocardial infarction. Circulation 2007;116:721-728.
16. Huber K, Goldstein P, Danchin N, Fox KAA. Network models for large cities: the European experience. Heart 2010;96:164-169.
17. Jollis JG, Granger CB, Henry TD, Antman EM, Berger PB, Moyer PH, Pratt FD, Rokos IC, Acuña AR, Roettig ML, Jacobs AK. Systems of care for STsegment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline. Circ Cardiovasc Qual Outcomes 2012;5:423-428.
18. Jollis JG, Roettig ML, Aluko AO, Anstrom KJ, Applegate RJ, Babb JD, Berger PB, Bohle DJ, Fletcher SM, Garvey JL, Hathaway WR, Hoekstra JW, Kelly RV, Maddox WTJ, Shiber JR, Valeri FS,Watling BA, Wilson BH, Granger CB. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA 2007;298:2371-2380.
19. Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, SchreiberW, Unger G, GlogarH, Kaff A, Laggner A, Maurer G, Mlczoch J, Slany J,Weber H, Huber K; for the Vienna STEMI Registry Group. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 2006;113:2398-2405.
20. Nallamothu BK,KrumholzHM,KoDT, LaBresh KA, Rathore S,RoeMT,SchwammL. Development of systems of care for ST-elevation myocardial infarction patients: gaps, barriers, and implications. Circulation 2007;116:e68-e72.
21. Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, Lim CC, Bresnahan JF, Jaffe AS, Holmes DR, Bell MR. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation 2007;116:729-736.
22. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Ortiz FR, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F; for the STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013; 1379-1387.
23. Fosbol EL, Granger CB, Jollis JG, Monk L, Lin L, Lytle BL, Xian Y, Garvey JL, Mears G, Corbett CC, Peterson ED, Glickman SW. The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times. Circulation 2013;127:604-612.
24. ArmstrongPW, Boden WE. Reperfusion paradox in ST-segment elevation myocardial infarction. Ann Intern Med 2011;155:389-391.
25. Lambert L, Brown K, Segal E, Brophy J, Rodes-Cabau J, Bogaty P. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA 2010;303:2148-2155.
26. RoeMT, Messenger JC,Weintraub WS, Cannon CP, Fonarow GC, Dai D, Chen AY, Klein LW, Masoudi FA, McKay C, Hewitt K, Brindis RG, Peterson ED, Rumsfeld JS. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol 2010;56:254-263.
27. Terkelsen CJ, Sørensen JT, Maeng M, Jensen LO, Tilsted HH, Trautner S, Vach W, Johnsen SP, Thuesen L, Lassen JF. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 2010;304:763-771.
28. Williams DO. Treatment delayed is treatment denied. Circulation 2004;109: 1806-1808.
29. Bagai A, Granger CB. STREAMlining care for patients with STEMI. Nat Rev Cardiol 2013;10:304-306.
30. Menees DS, Peterson ED,Wang Y, Curtis JP, Messenger JC, Rumsfeld JS, Gurm HS. Door-to-balloon time and mortality among patients undergoing primary PCI.NEngl J Med 2013;369:901-909.
31. Huber K, Holmes DE, van't Hof AW, Montalescot G, Betriu A, Widimsky P, WesterhoutCM, Granger CB, ArmstrongPW. Use of glycoprotein IIb/IIIa-inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. Eur Heart J 2010;31:1708-1716.
32. Rakowski T, Zalewski J, Legutko J, Bartus S, Rzeszutko L, Dziewierz A, Sorysz D, Bryniarski L, Zmudka K, Kaluza GL, Dubiel JS, Dudek D. Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study. Am Heart J 2007;153:360-365.
33. Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, MieleckiW, Depukat R, Janzon M, Stefaniak J, Zmudka K, Dubiel JS, Partyka L, Dudek D. Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with highrisk profile. Results fromEUROTRANSFER registry. Am Heart J 2009;158:569-575.
34. Montalescot G, Bolognese L, Dudek D, Goldstein P,HammC, Tanguay JF, ten Berg J, Widimsky P, Luo J, Miller DL, Goedicke J. A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study. Am Heart J 2011;161:650-656.
35. Montalescot G, Lassen JF,HammCW, Lapostolle F, Silvain J, ten Berg JM, Cantor WJ, Goodman SG, Licour M, Tsatsaris A, van't HofAW. Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study. Am Heart J 2013;165:515-522.
36. Alexopoulos D, Xanthopoulou I, Gkizas V, Kassimis G, Theodoropoulos KC, Makris G, Koutsogiannis N, Damelou A, Tsigkas G, Davlouros P, Hahalis G. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST elevation myocardial infarction. Circ Cardiovasc Interv 2012;5:797-804.
37. Valgimigli M, Tebaldi M, Campo G, Gambetti S, Bristot L, Monti M, Parrinello G, Ferrari R. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. JACC Cardiovasc Interv 2012;5:268-277.
38. Kristensen SD, Würtz M, Grove EL, De Caterina R, Huber K, Moliterno DJ, Neumann FJ. Contemporary use of glycoprotein IIb/IIIa inhibitors. Thromb Haemostas 2013;107:215-224.
39. Angiolillo DJ, Schneider DJ, Bhatt DL, French WJ, Price MJ, Saucedo JF, ShaburishviliT, Huber K, Prats J, LiuT, Harrington RA, Becker RC. Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials. J Thrombos Thrombolysis 2013;34:44-55.
40. Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, Price MJ, Leonardi S, Gallup D, Bramucci E, Radke PW, Widimsky P, Tousek F, Tauth J, Spriggs D, McLaurin BT, Angiolillo DJ, Généreux P, Liu T, Prats J, Todd M, Skerjanec S, White HD, Harrington RA; CHAMPION PHOENIX Investigators. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 2013;368:1303-1313.
41. Steg PG, van't Hof A, HammCW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Campo dell' Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P; EUROMAX Investigators. Bivalirudin started during emergency transport for primary PCI. N Engl J Med 2013;369: 2207-2217.
42. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-2230.
43. Widimsky P, WijnsW, Fajadet J, de Belder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, Betriu A, ClaeysM, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, Kristensen SD, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M, Radovanovic D, De Servi S, Stenestrand U, Studencan M, TubaroM, Vasiljevic Z,Weidinger F, Witkowski A, Zeymer U. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010;31:943-957.
44. Aissaoui N, Puymirat E, Tabone X, Charbonnier B, Schiele F, Lefèvre T, Durand E, Blanchard D, Simon T, Cambou JP, Danchin N. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J 2012;33: 2535-2543.
45. Hanssen M, Cottin Y, Khalife K, Hammer L, Goldstein P, Puymirat E, Mulak G, Drouet E, Pace B, Schultz E, Bataille V, Ferrières J, Simon T, Danchin N; FAST-MI 2010 Investigators. French registryonacute ST-elevation and non ST-elevation myocardial infarction 2010. FAST-MI 2010. Heart 2012;98:699-705.
46. Herrin J, Miller LE, Turkmani DF, NsaW, Drye EE, Bernheim SM, Ling SM, Rapp MT, Han LF, BratzlerDW, Bradley EH, Nallamothu BK, Ting HH, Krumholz HM. National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention. Arch Intern Med 2011;171:1879-1886.
47. Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, Davies RF, Sherrard HL, Maloney J, Marquis JF, O'Brien ER, Trickett J, Poirier P, Ryan SC, Ha A, Joseph PG, Labinaz M. Acitywide protocol for primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2008;358:231-240.
48. Flynn A, Moscucci M, Share D, Smith D, LaLonde T, Changezi H, Riba A, Gurm HS. Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Arch Intern Med 2010;170:1842-1849.
49. Gibson CM, Pride YB, Frederick PD, Pollack CVJ, Canto JG, Tiefenbrunn AJ, Weaver DW, Lambrew CT, French WJ, Peterson ED, Rogers WJ; for the NRMI Investigators. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008;156:1035-1044.
50. Garvey JL, Monk L, Granger CB, Studnek JR, Roettig ML, Corbett CC, Jollis JG. Rates of cardiac catheterization cancelation for ST-segment elevation myocardial infarction after activation by emergency medical services or emergency physicians: results from the North Carolina Catheterization Laboratory Activation Registry. Circulation 2012;125:308-313.
51. Brodie BR, Gersh B, Stuckey T, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Grines CL, Cox D, Parise H, Prasad A, Lansky AJ, Mehran R, Stone GW. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. J Am Coll Cardiol 2010;56:407-413.
52. Grines CL, SchreiberT. Primary percutaneous coronary intervention: the deception of delay. J Am Coll Cardiol 2013;61:1696-1697.
53. Concannon TW, Nelson J, Kent DM, Griffith JL. Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcomes 2013;6:400-408.
54. Bagai A, Al-Khalidi HR, SherwoodMW, MuñozD, Roettig ML, Jollis JG, Granger CB. Regional systems of care demonstration project: mission: Lifeline STEMI Systems Accelerator: design and methodology. Am Heart J 2014;167:15-21.
55. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, Gupta R, Joshi P, Kerkar P, Thanikachalam S, Haridas KK, Jaison TM, Naik S, Maity AK, Yusuf S; CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008; 371:1435-1442.
56. Alexander T, Mehta S, Mullasari A, Nallamothu BK. Systems of care for ST-elevation myocardial infarction in India: is it time? Heart 2012;98:15-17.
57. Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, Liao ML, Zhang JS, Hu J, Yang ZK, Shen WF. One-year clinical outcome of interventionalist-versus patienttransfer strategies for primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results from the REVERSE-STEMI study. Circ Cardiovasc Qual Outcomes 2011;4:355-362.
58. ZhangY,HuoY. Early reperfusion strategy for acute myocardial infarction: a need for clinical implementation. J Zhejiang Univ Sci B 2011;12:629-632.
59. Song L, Yan HB, Yang JG, Sun YH, Li C; Emergency Rescue System of Myocardial Infarction Collaborating Group. Analysis on inter-hospital transfer in patients with acute myocardial infarction in Beijing. Zhonghua Xin Xue Guan Bing Za Zhi 2010;38: 406-410.
60. Ranasinghe I, Turnbull F, Tonkin A, Clark RA, Coffee N, Brieger D. Comparative effectiveness of population interventions to improve access to reperfusion for ST-segment-elevation myocardial infarction in Australia. Circ Cardiovasc Qual Outcomes 2012;5:429-436.
61. Chew DP, Blows LJ. Randomized trials of clinical networks in the management of ST-elevation MI: can they be performed? Curr Opin Cardiol 2009;24:301-306.
62. Al-Zakwani I, Zubaid M, Al-Riyami A, Alanbaei M, Sulaiman K, Almahmeed W, Al-Motarreb A, Al-Suwaidi J. Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East. Int J Clin Pharm 2012; 34:445-451.
63. Alhabib KF, Jolly SS, Yusuf S, Alsheikh-Ali AA, Al Suwaidi J, Hersi A, Sulaiman K, Al Saif S, Almahmeed W, Asaad N, Amin H, Al-Motarreb A, Alfaleh H, Alnemer K, Thalib L. Impact of access to hospitals with catheterization facilities in the second Gulf Registry of Acute Coronary Events (Gulf RACE-2). Coron Artery Dis 2013;24: 412-418.
64. Shehab A, Al-Dabbagh B, Al-Habib KF, Alsheikh-Ali AA, AlmahmeedW, Sulaiman K, Al-Motarreb A, Nagelkerke N, Al-Suwaidi J, Hersi A, Al-Faleh H, Asaad N, Al-Saif S, Amin H. Gender disparities in the presentation, management and outcomes of acute coronary syndrome patients: data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2). PLoS One 2013;8:e55508.
65. Solla DJ, Paiva Filho Ide M, Delisle JE, Braga AA, Moura JB, Moraes XDJ, FilgueirasNM, Carvalho ME, Martins MS, Manganotti Neto O, Roberto Filho P, Roriz Pde S. Integrated regional networks for ST-segment-elevation myocardial infarction care in developing countries: the experience of Salvador, Bahia, Brazil. Circ Cardiovasc Qual Outcomes 2013;6:9-17.
66. Hellig F. Strategies in mechanical intervention for acute MI: facilitated and rescue PCI. S A Heart J 2008;5:52-57.
67. Jolly SS, Cairns J, Yusuf S, Niemela K, Steg PG, Worthley M, Ferrari E, Cantor WJ, Fung A, Valettas N, Rokoss M, Olivecrona G, Widimsky P, Cheema AN, Gao P, Mehta SR. Procedural volume and outcomes with radial or femoral access for coronary angiography and intervention. J Am Coll Cardiol 2014;63:954-963.